These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38159855)

  • 41. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Receptor activator of NF-{kappa}B (RANK) cytoplasmic IVVY535-538 motif plays an essential role in tumor necrosis factor-{alpha} (TNF)-mediated osteoclastogenesis.
    Jules J; Shi Z; Liu J; Xu D; Wang S; Feng X
    J Biol Chem; 2010 Nov; 285(48):37427-35. PubMed ID: 20870724
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Macrophage colony-stimulating factor pretreatment of bone marrow progenitor cells regulates osteoclast differentiation based upon the stage of myeloid development.
    Yang X; Pande S; Scott C; Friesel R
    J Cell Biochem; 2019 Aug; 120(8):12450-12460. PubMed ID: 30805994
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An Antibody to Notch2 Reverses the Osteopenic Phenotype of Hajdu-Cheney Mutant Male Mice.
    Canalis E; Sanjay A; Yu J; Zanotti S
    Endocrinology; 2017 Apr; 158(4):730-742. PubMed ID: 28323963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RANKL-stimulated osteoclast-like cell formation in vitro is partially dependent on endogenous interleukin-1 production.
    Lee SK; Gardner AE; Kalinowski JF; Jastrzebski SL; Lorenzo JA
    Bone; 2006 May; 38(5):678-85. PubMed ID: 16309985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. M-CSF priming of osteoclast precursors can cause osteoclastogenesis-insensitivity, which can be prevented and overcome on bone.
    De Vries TJ; Schoenmaker T; Aerts D; Grevers LC; Souza PP; Nazmi K; van de Wiel M; Ylstra B; Lent PL; Leenen PJ; Everts V
    J Cell Physiol; 2015 Jan; 230(1):210-25. PubMed ID: 24962140
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dexamethasone enhances osteoclast formation synergistically with transforming growth factor-beta by stimulating the priming of osteoclast progenitors for differentiation into osteoclasts.
    Takuma A; Kaneda T; Sato T; Ninomiya S; Kumegawa M; Hakeda Y
    J Biol Chem; 2003 Nov; 278(45):44667-74. PubMed ID: 12944401
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Follistatin-like 1 promotes osteoclast formation via RANKL-mediated NF-κB activation and M-CSF-induced precursor proliferation.
    Kim HJ; Kang WY; Seong SJ; Kim SY; Lim MS; Yoon YR
    Cell Signal; 2016 Sep; 28(9):1137-1144. PubMed ID: 27234130
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miR-142-5p promotes the osteoclast differentiation of bone marrow-derived macrophages via PTEN/PI3K/AKT/FoxO1 pathway.
    Lou Z; Peng Z; Wang B; Li X; Li X; Zhang X
    J Bone Miner Metab; 2019 Sep; 37(5):815-824. PubMed ID: 30900017
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis.
    Kimachi K; Kajiya H; Nakayama S; Ikebe T; Okabe K
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):297-308. PubMed ID: 21225243
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of osteoclastogenesis by RNA interference targeting RANK.
    Ma R; Xu J; Dong B; Kauther MD; Jäger M; Wedemeyer C
    BMC Musculoskelet Disord; 2012 Aug; 13():154. PubMed ID: 22913338
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Presence of osteoclast precursors in colonies cloned in the presence of hematopoietic colony-stimulating factors.
    Yamazaki H; Kunisada T; Yamane T; Hayashi SI
    Exp Hematol; 2001 Jan; 29(1):68-76. PubMed ID: 11164107
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro.
    Wang L; Zhao R; Shi X; Wei T; Halloran BP; Clark DJ; Jacobs CR; Kingery WS
    Bone; 2009 Aug; 45(2):309-20. PubMed ID: 19379851
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increasing membrane-bound MCSF does not enhance OPGL-driven osteoclastogenesis from marrow cells.
    Fan X; Fan D; Gewant H; Royce CL; Nanes MS; Rubin J
    Am J Physiol Endocrinol Metab; 2001 Jan; 280(1):E103-11. PubMed ID: 11120664
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dominant negative N-cadherin inhibits osteoclast differentiation by interfering with beta-catenin regulation of RANKL, independent of cell-cell adhesion.
    Shin CS; Her SJ; Kim JA; Kim DH; Kim SW; Kim SY; Kim HS; Park KH; Kim JG; Kitazawa R; Cheng SL; Civitelli R
    J Bone Miner Res; 2005 Dec; 20(12):2200-12. PubMed ID: 16294273
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of age on regulation of human osteoclast differentiation.
    Chung PL; Zhou S; Eslami B; Shen L; LeBoff MS; Glowacki J
    J Cell Biochem; 2014 Aug; 115(8):1412-9. PubMed ID: 24700654
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinically Relevant Concentrations of Ketamine Inhibit Osteoclast Formation In Vitro in Mouse Bone Marrow Cultures.
    Du E; McAllister P; Venna VR; Xiao L
    J Cell Biochem; 2017 Apr; 118(4):914-923. PubMed ID: 27775174
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vitamin C-deficiency stimulates osteoclastogenesis with an increase in RANK expression.
    Hie M; Tsukamoto I
    J Nutr Biochem; 2011 Feb; 22(2):164-71. PubMed ID: 20444587
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of osteoclastogenesis by interleukin-33 administration in the periodontal ligament under mechanical loading.
    Dong X; Feng J; Li B; Bai D; Xu H
    J Periodontal Res; 2022 Oct; 57(5):1003-1013. PubMed ID: 35930702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.